Zhu, J.Q., Zhong, W.Z., Zhang, G.C., et al. (2008) Better Sur-vival with EGFR Exon 19 than Exon 2 Mutations in Gefltinlb-Treated Non-Small Cell Lung Cancer Patients Is Due to Differential Inhibition of Downstream Signals. Cancer Letters, 265, 307-317.